| # | Title | Journal | Year | Citations |
|---|
| 1 | Molecular Genetics of Attention-Deficit/Hyperactivity Disorder | Biological Psychiatry | 2005 | 1,968 |
| 2 | Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 1,258 |
| 3 | Neurocognition in first-episode schizophrenia: A meta-analytic review. | Neuropsychology | 2009 | 960 |
| 4 | Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder | Science | 2018 | 805 |
| 5 | PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease | Science Translational Medicine | 2010 | 691 |
| 6 | Decreased volume of left and total anterior insular lobule in schizophrenia | Schizophrenia Research | 2006 | 592 |
| 7 | Patterns and Predictors of Attention-Deficit/Hyperactivity Disorder Persistence into Adulthood: Results from the National Comorbidity Survey Replication | Biological Psychiatry | 2005 | 571 |
| 8 | Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders | Biological Psychiatry | 2010 | 565 |
| 9 | The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice | Science Advances | 2019 | 446 |
| 10 | Environmental risk factors for attention‐deficit hyperactivity disorder | Acta Paediatrica, International Journal of Paediatrics | 2007 | 441 |
| 11 | Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder | Human Molecular Genetics | 2006 | 433 |
| 12 | How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD | Psychiatry Research | 2010 | 379 |
| 13 | Genome-wide association studies in ADHD | Human Genetics | 2009 | 374 |
| 14 | Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2005 | 347 |
| 15 | A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes | Journal of Clinical Psychiatry | 2010 | 322 |
| 16 | Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial | Lancet, The | 2018 | 290 |
| 17 | A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication | Molecular Psychiatry | 2010 | 245 |
| 18 | Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses | Translational Psychiatry | 2019 | 237 |
| 19 | Meta-analysis of 32 genome-wide linkage studies of schizophrenia | Molecular Psychiatry | 2009 | 235 |
| 20 | The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale forDSM-5 | JAMA Psychiatry | 2017 | 230 |
| 21 | Perfectionism | Comprehensive Psychiatry | 1965 | 224 |
| 22 | Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2005 | 220 |
| 23 | Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study | Pediatrics | 2009 | 215 |
| 24 | Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence | Molecular Psychiatry | 2009 | 196 |
| 25 | Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia | Journal of Clinical Psychopharmacology | 2013 | 194 |
| 26 | Symptoms Versus Impairment | Journal of Attention Disorders | 2006 | 190 |
| 27 | Substance Use among ADHD Adults: Implications of Late Onset and Subthreshold Diagnoses | American Journal on Addictions | 2007 | 187 |
| 28 | Convergent functional genomics of genome‐wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2009 | 178 |
| 29 | The spontaneously hypertensive rat model of ADHD – The importance of selecting the appropriate reference strain | Neuropharmacology | 2009 | 176 |
| 30 | Delay and reward choice in ADHD: An experimental test of the role of delay aversion. | Neuropsychology | 2009 | 173 |
| 31 | Emotional Health Predicts Pain and Function After Fusion: A Prospective Multicenter Study | Spine | 2006 | 169 |
| 32 | Developmentally Stable Whole-Brain Volume Reductions and Developmentally Sensitive Caudate and Putamen Volume Alterations in Those With Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings | JAMA Psychiatry | 2015 | 159 |
| 33 | Is Cigarette Smoking a Gateway to Alcohol and Illicit Drug Use Disorders? A Study of Youths with and without Attention Deficit Hyperactivity Disorder | Biological Psychiatry | 2006 | 154 |
| 34 | Psychiatric medication-induced obesity: a review | Obesity Reviews | 2004 | 150 |
| 35 | Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trial | Drug and Alcohol Dependence | 2007 | 143 |
| 36 | Identification of blood biomarkers for psychosis using convergent functional genomics | Molecular Psychiatry | 2011 | 143 |
| 37 | The role of brain oscillations as functional correlates of cognitive systems: a study of frontal inhibitory control in alcoholism | International Journal of Psychophysiology | 2004 | 142 |
| 38 | Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia | Frontiers in Pharmacology | 2012 | 142 |
| 39 | Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia | Nature Communications | 2018 | 141 |
| 40 | Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients | Drug and Alcohol Dependence | 2013 | 135 |
| 41 | Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD | Acta Psychiatrica Scandinavica | 2007 | 133 |
| 42 | Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms: implications for human brain dynamics and cognition | International Journal of Psychophysiology | 2004 | 132 |
| 43 | Psychiatric Symptoms in Systemic Lupus Erythematosus | Journal of Clinical Psychiatry | 2012 | 126 |
| 44 | Antidepressant efficacy and side-effect burden: a quick guide for clinicians | Drugs in Context | 2015 | 125 |
| 45 | The Role of Atypical Antipsychotics in the Treatment of Delirium | Psychosomatics | 2002 | 124 |
| 46 | Neuropsychological Functioning in Adolescents and Young Adults at Genetic Risk for Schizophrenia and Affective Psychoses: Results from the Harvard and Hillside Adolescent High Risk Studies | Schizophrenia Bulletin | 2005 | 124 |
| 47 | Axis I and II comorbidity in adults with ADHD. | Journal of Abnormal Psychology | 2007 | 124 |
| 48 | The relationship between marital quality and adherence to the diabetes care regimen | Annals of Behavioral Medicine | 2004 | 123 |
| 49 | Towards understanding the schizophrenia code: An expanded convergent functional genomics approach | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2007 | 123 |
| 50 | Altered brain activation in dorsolateral prefrontal cortex in adolescents and young adults at genetic risk for schizophrenia: An fMRI study of working memory | Schizophrenia Research | 2006 | 120 |
